Clinical Trials Directory

Trials / Unknown

UnknownNCT03702348

Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever

Effect of a Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever: Randomized Clinical Trial

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Universidade Federal de Pernambuco · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Common symptoms of chikungunya fever are persistent arthritis and arthralgia, such symptoms can lead to impairment in functionality. The objective of this study is to evaluate the efficacy of a resistance exercise protocol on the functionality of individuals with chronic musculoskeletal manifestations of Chikungunya fever. Quality of life, number of painful joints, intensity of pain, number of recurrence of exacerbation and thermography are secondary outcomes that will also be evaluated. The protocol uses elastic resistance to strengthen muscle groups that stabilize the main joints affected by Chikungunya Fever. The sessions will be 2 times a week for 12 weeks. The control group will not be submitted to the intervention during the 12 weeks, being contacted through telephone calls. After the reevaluation at the end of the 12 weeks the control group will perform the same protocol. The sample will be characterized and the effect size and the mean difference will be calculated. Intention-to-treat analysis and rate of adherence will also be calculated.

Conditions

Interventions

TypeNameDescription
OTHERResistance exerciseProtocol with 5min warm-up exercise and 8 exercises that progress in positioning and resistance based on maximum repetition test. The exercises strengthen both the lower and upper limbs and are intended to simulate activities such as sitting and standing up, climbing stairs, picking up weight ...

Timeline

Start date
2018-07-23
Primary completion
2019-10-01
Completion
2019-11-01
First posted
2018-10-11
Last updated
2019-09-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03702348. Inclusion in this directory is not an endorsement.